25 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
ASMB Assembly Biosciences, Inc. $34.41 $875.61M Downtrend
Article Searches
Assembly Biosciences (ASMB) Reports Q3 Loss, Tops Revenue Estimates http://www.zacks.com/stock/news/336439/assembly-biosciences-asmb-reports-q3-loss-tops-revenue-estimates?cid=CS-ZC-FT-336439 Nov 08, 2018 - Assembly Biosciences (ASMB) delivered earnings and revenue surprises of 14.71% and 33.40%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Assembly Biosciences (ASMB) to Report a Decline in Earnings: What to Look Out for http://www.zacks.com/stock/news/333438/analysts-estimate-assembly-biosciences-asmb-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-333438 Oct 31, 2018 - Assembly Biosciences (ASMB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Recent Assembly Biosciences Weakness Provides Attractive Entry Point, B Riley FBR Says In Upgrade http://feeds.benzinga.com/~r/benzinga/~3/luY90gjuCRE/recent-assembly-biosciences-weakness-provides-attractiv Oct 08, 2018 -

Assembly Biosciences Inc (NASDAQ: ASMB) shares have shed over one-fourth of their value since late September, creating an opportunity to buy the dip, B. Riley FBR said Monday. 

ASMB: B. Riley FBR ups to Buy http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20181008073922 Oct 08, 2018 - B. Riley FBR issues rating change for ASMB
Assembly Biosciences announces pricing of common stock https://seekingalpha.com/news/3369517-assembly-biosciences-announces-pricing-common-stock?source=feed_news_all Jul 11, 2018 - Assembly Biosciences (NASDAQ:ASMB) priced public offering of 4M common at $36/share for gross proceeds of $144M.Underwriters have a 30-day option to purchase up to an additional 0.6M common shares.Th
Bulletproof Investing Performance Update: Week 27 https://seekingalpha.com/article/4178728-bulletproof-investing-performance-update-week-27?source=feed_tag_etf_portfolio_strategy Jun 01, 2018 - It's been six months since I presented 4 hedged portfolios and 10 top names in week 27 of my Marketplace service (November 30th). Here's how everything did. This was the worst week yet. All 4 portfoli
Assembly Biosciences misses by $0.04, beats on revenue https://seekingalpha.com/news/3353430-assembly-biosciences-misses-0_04-beats-revenue?source=feed_news_all May 07, 2018 - Assembly Biosciences (NASDAQ:ASMB): Q1 EPS of -$0.80 misses by $0.04.Revenue of $3.57M (+425.0% Y/Y) beats by $1.69M.Press Release
Chardan: Assembly Biosciences Hep B Antiviral Data 'Positive,' But Undifferentiated From Competitor Johnson & Johnson http://feeds.benzinga.com/~r/benzinga/~3/jUwycB6z290/chardan-assembly-biosciences-hep-b-antiviral-data-posit Apr 13, 2018 -

Assembly Biosciences Inc (NASDAQ: ASMB) made a poster presentation of interim results from two early-stage studies for its ABI-H073, a

Latest Ratings for ASMB

DateFirmActionFromTo
Apr 2018Chardan CapitalDowngradesBuyNeutral
Jan 2018B. RileyInitiates Coverage OnNeutral
Nov 2017JefferiesInitiates Coverage OnBuy

View More Analyst Ratings for ASMB
View the Latest Analyst Ratings

Your Daily Pharma Scoop: Reata Provides Update, Assembly Biosciences Data, Bellicum's BPX-501 https://seekingalpha.com/article/4162760-daily-pharma-scoop-reata-provides-update-assembly-biosciences-data-bellicums-bpxminus-501?source=feed_sector_healthcare Apr 13, 2018 - Reata provided an update on the CARDINAL study of bardoxolone.Assembly Biosciences reports results for ABI-H0731.FDA lifts clinical hold on Bellicum’s BPX-501 studies.
ASMB: Chardan Capital Markets cuts to Neutral http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20180413073148 Apr 13, 2018 - Chardan Capital Markets issues rating change for ASMB

Pages: 123

Page 1>

Related Companies

Name Exchange Price Mkt Cap
RCKT Rocket Pharmaceuticals, Inc. NASDAQ $22.24 $882.06M
RVNC Revance Therapeutics, Inc. NASDAQ $23.5001 $868.04M
AMPH Amphastar Pharmaceuticals, Inc. NASDAQ $18.33 $847.88M
AMRN Amarin Corporation plc NASDAQ $2.83 $838.67M
CTMX CytomX Therapeutics, Inc. NASDAQ $18.52 $832.73M
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Assembly Biosciences
ASMB - Google Finance https://www.google.com/finance?q=ASMB Industry related info and international coverage Summary News
ASMB - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=ASMB Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options